Camille Hochheimer
Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Early Detection of Cancer | 5 | 2020 | 506 | 1.050 |
Why?
| | Patient Dropouts | 2 | 2019 | 65 | 1.040 |
Why?
| | Inservice Training | 1 | 2024 | 115 | 0.770 |
Why?
| | Barrett Esophagus | 3 | 2026 | 172 | 0.520 |
Why?
| | Internet | 2 | 2019 | 660 | 0.460 |
Why?
| | Decision Making | 2 | 2019 | 993 | 0.420 |
Why?
| | Colonic Polyps | 2 | 2024 | 87 | 0.380 |
Why?
| | Antihypertensive Agents | 1 | 2017 | 519 | 0.370 |
Why?
| | Respiration | 2 | 2024 | 208 | 0.370 |
Why?
| | Surveys and Questionnaires | 5 | 2025 | 6073 | 0.310 |
Why?
| | Esophageal Neoplasms | 2 | 2026 | 351 | 0.310 |
Why?
| | Primary Health Care | 6 | 2024 | 1776 | 0.300 |
Why?
| | Opiate Substitution Treatment | 2 | 2024 | 195 | 0.280 |
Why?
| | Clinical Competence | 4 | 2025 | 1272 | 0.270 |
Why?
| | Hypertension | 1 | 2017 | 1272 | 0.270 |
Why?
| | Electronic Health Records | 1 | 2016 | 1210 | 0.270 |
Why?
| | Buprenorphine | 2 | 2024 | 197 | 0.270 |
Why?
| | Lung Neoplasms | 1 | 2020 | 2675 | 0.240 |
Why?
| | Respiratory Rate | 2 | 2024 | 24 | 0.230 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2026 | 42 | 0.230 |
Why?
| | Wound Infection | 1 | 2026 | 60 | 0.220 |
Why?
| | Residence Characteristics | 2 | 2019 | 385 | 0.220 |
Why?
| | Periodontics | 1 | 2025 | 11 | 0.220 |
Why?
| | Students, Dental | 1 | 2025 | 20 | 0.210 |
Why?
| | Education, Dental | 1 | 2025 | 38 | 0.210 |
Why?
| | Family Practice | 2 | 2018 | 422 | 0.210 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2024 | 74 | 0.200 |
Why?
| | Esophagoscopy | 1 | 2026 | 223 | 0.200 |
Why?
| | Morals | 1 | 2025 | 84 | 0.200 |
Why?
| | Physicians, Women | 1 | 2025 | 92 | 0.200 |
Why?
| | Attitude of Health Personnel | 2 | 2024 | 1219 | 0.190 |
Why?
| | Comparative Effectiveness Research | 1 | 2024 | 171 | 0.190 |
Why?
| | Comprehension | 1 | 2025 | 175 | 0.190 |
Why?
| | Colorectal Neoplasms | 3 | 2020 | 874 | 0.190 |
Why?
| | Opioid-Related Disorders | 2 | 2024 | 634 | 0.190 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2023 | 74 | 0.180 |
Why?
| | Time-to-Treatment | 1 | 2024 | 257 | 0.180 |
Why?
| | Sunlight | 1 | 2022 | 78 | 0.180 |
Why?
| | Humans | 28 | 2026 | 146342 | 0.180 |
Why?
| | Nursing Staff, Hospital | 1 | 2024 | 146 | 0.180 |
Why?
| | Male | 17 | 2026 | 73396 | 0.170 |
Why?
| | Colonoscopy | 1 | 2024 | 257 | 0.170 |
Why?
| | Adenocarcinoma | 2 | 2026 | 927 | 0.170 |
Why?
| | Clinical Trials as Topic | 1 | 2026 | 1064 | 0.160 |
Why?
| | Narcotic Antagonists | 2 | 2024 | 210 | 0.160 |
Why?
| | Water Purification | 1 | 2022 | 156 | 0.160 |
Why?
| | Adult | 11 | 2025 | 41087 | 0.160 |
Why?
| | Gastroesophageal Reflux | 1 | 2022 | 232 | 0.150 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 266 | 0.150 |
Why?
| | Aged | 10 | 2026 | 26432 | 0.150 |
Why?
| | Female | 18 | 2026 | 79499 | 0.150 |
Why?
| | Analgesics, Opioid | 2 | 2019 | 1221 | 0.140 |
Why?
| | Unemployment | 1 | 2019 | 43 | 0.140 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2026 | 1160 | 0.140 |
Why?
| | Transportation | 1 | 2019 | 54 | 0.140 |
Why?
| | Loneliness | 1 | 2019 | 69 | 0.130 |
Why?
| | Burnout, Professional | 1 | 2025 | 493 | 0.130 |
Why?
| | Income | 1 | 2019 | 206 | 0.130 |
Why?
| | Wounds and Injuries | 1 | 2026 | 959 | 0.130 |
Why?
| | Dominican Republic | 1 | 2017 | 29 | 0.130 |
Why?
| | Patient Portals | 1 | 2017 | 52 | 0.120 |
Why?
| | Noncommunicable Diseases | 1 | 2017 | 21 | 0.120 |
Why?
| | Physicians, Family | 1 | 2018 | 179 | 0.120 |
Why?
| | Delivery, Obstetric | 1 | 2018 | 164 | 0.120 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 449 | 0.120 |
Why?
| | Child Health Services | 1 | 2018 | 189 | 0.120 |
Why?
| | Sepsis | 1 | 2023 | 669 | 0.120 |
Why?
| | Morphine | 1 | 2017 | 171 | 0.110 |
Why?
| | Physician-Patient Relations | 1 | 2020 | 597 | 0.110 |
Why?
| | Middle Aged | 10 | 2026 | 36619 | 0.110 |
Why?
| | Developing Countries | 1 | 2017 | 312 | 0.110 |
Why?
| | Health Status Disparities | 1 | 2018 | 322 | 0.110 |
Why?
| | Linear Models | 1 | 2017 | 857 | 0.110 |
Why?
| | Internship and Residency | 3 | 2025 | 1281 | 0.100 |
Why?
| | Patient Compliance | 1 | 2018 | 589 | 0.100 |
Why?
| | Medicare | 1 | 2020 | 920 | 0.100 |
Why?
| | Communication | 1 | 2020 | 980 | 0.100 |
Why?
| | Patient Participation | 1 | 2017 | 457 | 0.100 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1327 | 0.100 |
Why?
| | Ambulatory Care | 1 | 2018 | 628 | 0.090 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2017 | 300 | 0.090 |
Why?
| | United States | 5 | 2022 | 16136 | 0.090 |
Why?
| | Mass Screening | 1 | 2020 | 1307 | 0.090 |
Why?
| | Blood Pressure | 1 | 2017 | 1765 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2019 | 1107 | 0.080 |
Why?
| | Lung Diseases | 1 | 2017 | 787 | 0.080 |
Why?
| | Biomechanical Phenomena | 2 | 2024 | 874 | 0.080 |
Why?
| | Research Design | 2 | 2026 | 1143 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1408 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2786 | 0.070 |
Why?
| | Longitudinal Studies | 1 | 2017 | 3017 | 0.070 |
Why?
| | Virginia | 2 | 2019 | 57 | 0.070 |
Why?
| | Cross-Sectional Studies | 4 | 2025 | 5899 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 2219 | 0.070 |
Why?
| | Health Care Surveys | 2 | 2020 | 541 | 0.070 |
Why?
| | Risk Factors | 4 | 2026 | 10921 | 0.060 |
Why?
| | Neoplasms | 1 | 2022 | 2954 | 0.060 |
Why?
| | Ukraine | 1 | 2026 | 37 | 0.060 |
Why?
| | Warfare | 1 | 2026 | 99 | 0.060 |
Why?
| | North America | 1 | 2026 | 300 | 0.060 |
Why?
| | Gene-Environment Interaction | 1 | 2026 | 190 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2026 | 417 | 0.050 |
Why?
| | Respiratory Mechanics | 1 | 2024 | 74 | 0.050 |
Why?
| | Time Factors | 2 | 2026 | 7109 | 0.050 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2024 | 135 | 0.050 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2024 | 152 | 0.050 |
Why?
| | Formative Feedback | 1 | 2024 | 38 | 0.050 |
Why?
| | Computer-Assisted Instruction | 1 | 2024 | 69 | 0.050 |
Why?
| | Learning Curve | 1 | 2024 | 71 | 0.050 |
Why?
| | Prospective Studies | 2 | 2026 | 8123 | 0.050 |
Why?
| | National Cancer Institute (U.S.) | 1 | 2022 | 56 | 0.050 |
Why?
| | Hope | 1 | 2022 | 31 | 0.050 |
Why?
| | Plastics | 1 | 2022 | 50 | 0.050 |
Why?
| | Recurrence | 1 | 2026 | 1133 | 0.050 |
Why?
| | Proportional Hazards Models | 1 | 2026 | 1331 | 0.040 |
Why?
| | Water Microbiology | 1 | 2022 | 87 | 0.040 |
Why?
| | Motion | 1 | 2022 | 94 | 0.040 |
Why?
| | Colorado | 2 | 2024 | 4595 | 0.040 |
Why?
| | Antisocial Personality Disorder | 1 | 2022 | 123 | 0.040 |
Why?
| | Disinfection | 1 | 2022 | 131 | 0.040 |
Why?
| | Neoplasm Staging | 1 | 2024 | 1488 | 0.040 |
Why?
| | Perception | 1 | 2022 | 373 | 0.040 |
Why?
| | Birth Weight | 1 | 2023 | 521 | 0.040 |
Why?
| | Gestational Age | 1 | 2023 | 990 | 0.040 |
Why?
| | Vulnerable Populations | 1 | 2020 | 178 | 0.040 |
Why?
| | American Heart Association | 1 | 2021 | 364 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2023 | 6460 | 0.040 |
Why?
| | Heart Rate | 1 | 2023 | 846 | 0.040 |
Why?
| | Cholesterol | 1 | 2021 | 411 | 0.040 |
Why?
| | Incidence | 1 | 2026 | 2936 | 0.040 |
Why?
| | Geography | 1 | 2019 | 187 | 0.030 |
Why?
| | Escherichia coli | 1 | 2022 | 832 | 0.030 |
Why?
| | Altitude | 1 | 2022 | 469 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2024 | 881 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2024 | 17438 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2026 | 2488 | 0.030 |
Why?
| | Prostate-Specific Antigen | 1 | 2017 | 162 | 0.030 |
Why?
| | Injections, Spinal | 1 | 2017 | 120 | 0.030 |
Why?
| | Infant | 2 | 2023 | 10114 | 0.030 |
Why?
| | Mammography | 1 | 2017 | 175 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2026 | 5439 | 0.030 |
Why?
| | Anesthetics | 1 | 2017 | 100 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1707 | 0.030 |
Why?
| | Insurance, Health | 1 | 2018 | 318 | 0.030 |
Why?
| | Prenatal Care | 1 | 2018 | 310 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2017 | 216 | 0.030 |
Why?
| | Telemedicine | 1 | 2024 | 966 | 0.030 |
Why?
| | Poverty | 1 | 2018 | 530 | 0.030 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2017 | 193 | 0.030 |
Why?
| | Anesthesia | 1 | 2017 | 257 | 0.020 |
Why?
| | Patient Education as Topic | 1 | 2017 | 770 | 0.020 |
Why?
| | Pneumonia | 1 | 2018 | 635 | 0.020 |
Why?
| | Chronic Disease | 1 | 2018 | 1827 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2107 | 0.020 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2017 | 385 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3647 | 0.020 |
Why?
| | Qualitative Research | 1 | 2019 | 1734 | 0.020 |
Why?
| | Length of Stay | 1 | 2017 | 1358 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2026 | 11821 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2017 | 972 | 0.020 |
Why?
| | Exercise | 1 | 2022 | 2213 | 0.020 |
Why?
| | Vaccination | 1 | 2018 | 1449 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2018 | 1101 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1408 | 0.020 |
Why?
| | Body Mass Index | 1 | 2017 | 2458 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 6077 | 0.020 |
Why?
| | Blood Glucose | 1 | 2018 | 2360 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2017 | 2418 | 0.010 |
Why?
| | Obesity | 1 | 2018 | 3131 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11913 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 14330 | 0.010 |
Why?
| | Child | 1 | 2018 | 22693 | 0.010 |
Why?
|
|
Hochheimer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|